Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4921100

Cc1nc(C(=O)NCCS(C)(=O)=O)cc2c(Nc3cccc4c3CCO4)c(C(N)=O)cnc12.O=C(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 7/20 0.53
MTNR1B P49286 1/20 0.33
EED O75530 2/20 0.32
RBBP4 Q09028 2/20 0.32
SUZ12 Q15022 2/20 0.32
EZH2 Q15910 2/20 0.32
AEBP2 Q6ZN18 2/20 0.32
KIT P10721 1/20 0.32
BRAF P15056 1/20 0.32
CSF1R P07333 3/20 0.32
CSNK1D P48730 1/20 0.32
BRD4 O60885 2/20 0.32
BRD2 P25440 2/20 0.32
BRD3 Q15059 2/20 0.32
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
SCN7A Q01118 1/20 0.31
KCNH2 Q12809 1/20 0.31
SCN5A Q14524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14168749 0.95 PDE4B (0.58) PDE4BMTNR1BEEDRBBP4SUZ12
Trifluoroacetic Acid SCHEMBL4924249 0.88 PDE4B (0.48) PDE4BCYP3A4CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL4930184 0.87 PDE4B (0.47) PDE4BMTNR1BEEDRBBP4SUZ12
Trifluoroacetic Acid SCHEMBL4927212 0.86 PDE4B (0.46) PDE4B
Trifluoroacetic Acid SCHEMBL4928901 0.84 PDE4B (0.48) PDE4BMTNR1BEEDRBBP4SUZ12
Trifluoroacetic Acid SCHEMBL4929976 0.84 PDE4B (0.51) PDE4BMTNR1BEEDRBBP4SUZ12
Trifluoroacetic Acid SCHEMBL4928658 0.84 PDE4B (0.47) PDE4BMTNR1BCSF1RBRD4BRD2
Trifluoroacetic Acid SCHEMBL4926823 0.83 PDE4B (0.46) PDE4BMTNR1BBRD4BRD2BRD3
SCHEMBL4928534 0.83 PDE4B (0.59) PDE4BMTNR1BEEDRBBP4SUZ12
Trifluoroacetic Acid SCHEMBL4924460 0.82 PDE4B (0.44) PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080146563-A1 1,7-Naphthyridines as Pde4 Inhibitors GLAXO GROUP LIMITED 2008-06-19 US claimed
US-20080146563-A1 1,7-Naphthyridines as Pde4 Inhibitors GLAXO GROUP LIMITED 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146563-A1 1,7-Naphthyridines as Pde4 Inhibitors PDE4A, PDE3B, PDE4B PDE4B 3/4885MTNR1B 694/4885EED 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.